The industrial analytic x-ray division is one of three business units that German conglomerate Siemens AG plans to sell as part of its ongoing restructuring effort, the Munich company reported this month. Although the move does not affect the company's
The industrial analytic x-ray division is one of three business units that German conglomerate Siemens AG plans to sell as part of its ongoing restructuring effort, the Munich company reported this month. Although the move does not affect the company's Medical Engineering Group, there was some confusion about the group's status due to the way the news was reported in the international press.
Siemens is in the process of divesting some non-core businesses as part of a restructuring designed to improve profitability. The Medical Engineering Group, which includes the company's medical imaging operations, was rumored to be on the auction block earlier this year, but Siemens executives in July said they had no intention of selling the medical business (SCAN 8/6/97).
The divestiture rumors were briefly revived early this month after Siemens issued an announcement Sept. 2 that it was restructuring its industrial groups, which are not affiliated with Medical Engineering. Articles in European newspapers and wire services said Siemens would sell three businesses: x-ray equipment, communications test equipment, and electric wiring and lighting.
The news caused some Siemens observers to speculate about Medical Engineering's future at Siemens, but this was ultimately due to a misunderstanding: The press reports should have specified that the x-ray equipment unit mentioned was the company's industrial analytic x-ray activities, not Medical Engineering, according to a Siemens spokesperson. Siemens actually first announced it would sell the unit, Siemens Analytical X-ray Systems of Madison, WI, over a year ago.
MRI-Based AI Radiomics Model Offers 'Robust' Prediction of Perineural Invasion in Prostate Cancer
July 26th 2024A model that combines MRI-based deep learning radiomics and clinical factors demonstrated an 84.8 percent ROC AUC and a 92.6 percent precision-recall AUC for predicting perineural invasion in prostate cancer cases.
Breast MRI Study Examines Common Factors with False Negatives and False Positives
July 24th 2024The absence of ipsilateral breast hypervascularity is three times more likely to be associated with false-negative findings on breast MRI and non-mass enhancement lesions have a 4.5-fold likelihood of being linked to false-positive results, according to new research.
Can Polyenergetic Reconstruction Help Resolve Streak Artifacts in Photon Counting CT?
July 22nd 2024New research looking at photon-counting computed tomography (PCCT) demonstrated significantly reduced variation and tracheal air density attenuation with polyenergetic reconstruction in contrast to monoenergetic reconstruction on chest CT.